The status of New Haven's $20M community change grant remains particularly worrisome amid confusion following Trump's federal ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...